XML 23 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jul. 31, 2019
Income Statement [Abstract]      
Net sales $ 581,695,000 $ 616,715,000 $ 671,797,000
Cost of sales 367,737,000 389,882,000 424,357,000
Gross profit 213,958,000 226,833,000 247,440,000
Expenses:      
Selling, general and administrative 111,796,000 117,130,000 128,639,000
Research and development 49,148,000 52,180,000 56,407,000
Amortization of intangibles 21,020,000 21,595,000 18,320,000
Settlement of intellectual property litigation 0 0 (3,204,000)
Acquisition plan expenses 100,292,000 20,754,000 5,871,000
Total operating expenses 282,256,000 211,659,000 206,033,000
Operating (loss) income (68,298,000) 15,174,000 41,407,000
Other expenses (income):      
Interest expense 6,821,000 6,054,000 9,245,000
Write-off of deferred financing costs 0 0 3,217,000
Interest (income) and other (139,000) (190,000) 35,000
(Loss) income before (benefit from) provision for income taxes (74,980,000) 9,310,000 28,910,000
(Benefit from) provision for income taxes (1,500,000) 2,290,000 3,869,000
Net (loss) income $ (73,480,000) $ 7,020,000 $ 25,041,000
Net (loss) income per share:      
Basic (in dollars per share) $ (2.86) $ 0.28 $ 1.04
Diluted (in dollars per share) $ (2.86) $ 0.28 $ 1.03
Weighted average number of common shares outstanding - basic (in shares) 25,685,000 24,798,000 24,124,000
Weighted average number of common and common equivalent shares outstanding - diluted (in shares) 25,685,000 24,899,000 24,302,000